Skip to content
Events

Details

The inaugural Zero Childhood Cancer (ZERO) National Symposium being held from the 26-27 October 2022 at the NSW Teachers Federation Conference Centre in Sydney, NSW. The theme for the meeting “Towards Precision Oncology for All” will emphasize recent developments in pediatric cancer research, with an array of exceptional speakers at varying career stages, covering different areas. The content will cover a broad range of topics, relevant to the field of pediatric cancer, such as cancer biology and clinical translation and genetics, genomics and cancer predisposition.

Illumina is proud to be the leading partner for this monumental symposium. Visit the Illumina booth to learn how Illumina technologies is enabling novel insights into childhood cancer risk and treatment.

Illumina Virtual Industry Session

Date:

26 October 2022

Time:

5:00 - 5:30 pm

Topic:

Illumina Genomics Forum – the New NovaSeq X Series

Speakers:

Francis deSouza,
Chief Executive Officer,
Illumina Inc

Alex Aravanis,
Chief Technology Officer,
Illumina Inc
Date & Time
26 Oct. 2022 – 27 Oct. 2022
Location
NSW Teachers Federation Conference Centre, Sydney, NSW
Australia
South APAC
Topic
Cancer research, Oncology
This event has passed

Related Events

Apr 25
American Association for Cancer Research (AACR) Annual Meeting 2025
Apr 25, 2025 – Apr 30, 2025
Join us at Illumina booth 800 to learn how Illumina is driving innovation in cancer research and clinical solutions.
View Event
Apr 30
Liquid Biopsy Applications From Illumina
Apr 30, 2025
Liquid biopsy allows non-invasive detection and analysis of tumor-derived biomarkers in body fluids like blood, urine, and saliva, aiding in early detection, therapy selection, and disease monitoring. Liquid biopsy has the potential to expands access to precision medicine in cases where tissue biopsies are unavailable, have low tumor content or fail quality control metrics. Illumina’s broad liquid biopsy portfolio includes Pillar small panels, TruSight Oncology500 ctDNA v2 for comprehensive genomic profiling, and even exome and whole genome sequencing. Find out how Illumina’s library prep uses dual-strand unique molecular indexing (UMIs) and the DRAGEN enrichment pipeline, to minimize the risk of false positive, and lower the limit of detection while maintaining high specificity
View Event
May 6
Illumina Innovation Days
May 6, 2025 – Dec 2, 2025
Join us as we discuss new innovative technology offerings from the Illumina product pipeline and introduce our newest system – the MiSeq i100 Series.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.